SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001193125-19-061022
Filing Date
2019-03-01
Accepted
2019-03-01 16:28:48
Documents
9
Effectiveness Date
2019-03-01

Document Format Files

Seq Description Document Type Size
1 FORM S-3ASR d682648ds3asr.htm S-3ASR 251670
2 EX-4.1 d682648dex41.htm EX-4.1 283507
3 EX-5.1 d682648dex51.htm EX-5.1 24613
4 EX-23.2 d682648dex232.htm EX-23.2 1804
5 EX-23.3 d682648dex233.htm EX-23.3 1982
6 GRAPHIC g68264801.jpg GRAPHIC 8718
7 GRAPHIC g682648g01l09.jpg GRAPHIC 52441
8 GRAPHIC g682648g08i76.jpg GRAPHIC 1785
9 GRAPHIC g682648g47h85.jpg GRAPHIC 69082
  Complete submission text file 0001193125-19-061022.txt   746810
Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Filer) CIK: 0001723128 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-230022 | Film No.: 19649820
SIC: 2834 Pharmaceutical Preparations